title: The five steps of comprehensive psychosocial distress screening.
abstract: Despite the growing recognition of the impact psychosocial distress has on the quality of life of patients with cancer, the implementation of the National Comprehensive Cancer Network (NCCN) Distress Management Guidelines and the mandate of evidence-based policy for routine distress screening continue to lag. To speed adoption of the guideline, the American Psychosocial Oncology Society (APOS) and Yale School of Nursing (YSN) launched the Screening for Psychosocial Distress Program in 2014. The program resulted in the development of five steps necessary to carry out routine psychosocial distress screening. The steps are consistent with the NCCN Distress Management Guidelines and the new criterion for accreditation by the American College of Surgeons (ACS) Commission on Cancer as of 2015. These five steps are as follows: (1) screening, (2) evaluating, (3) referring, (4) following up, and (5) documenting and quality improvement. The purpose of this article is to summarize the detailed procedure of the five steps for cancer care professionals-including oncologists, nurses, psychiatrists, psychologists, and social workers-so they can manage psychosocial distress efficiently in their own clinical environments.
authors.affiliation: Yale University School of Nursing, PO Box 27399, West Haven, CT, 06516-7399, USA, mark.lazenby@yale.edu.
authors.forename: Mark
authors.initials: M
authors.lastname: Lazenby
authors.forename: Hui
authors.initials: H
authors.lastname: Tan
authors.forename: Nick
authors.initials: N
authors.lastname: Pasacreta
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Ercolano
authors.forename: Ruth
authors.initials: R
authors.lastname: McCorkle
mesh_terms: D002173:Cancer Care Facilities; D055317:Evidence-Based Practice; D005260:Female; D005500:Follow-Up Studies; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D009369:Neoplasms / Q000150:complications / Q000523:psychology*; D017410:Practice Guidelines as Topic; D011788:Quality of Life / Q000523:psychology; D012017:Referral and Consultation; D013315:Stress, Psychological / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy
references.citation: J Psychosoc Oncol. 2012;30(6):694-714
references.pmid: 23101552
references.citation: J Gen Intern Med. 2001 Sep;16(9):606-13
references.pmid: 11556941
references.citation: Palliat Support Care. 2014 Feb;12(1):63-8
references.pmid: 24468423
references.citation: Psychooncology. 2015 Jun;24(6):699-704
references.pmid: 25345693
references.citation: Palliat Support Care. 2014 Feb;12(1):1-4
references.pmid: 23915975
references.citation: J Clin Oncol. 2010 Nov 20;28(33):4884-91
references.pmid: 20940193
references.citation: Arch Gen Psychiatry. 2005 Jun;62(6):617-27
references.pmid: 15939839
references.citation: Clin J Oncol Nurs. 2014 Oct;18(5):598-600
references.pmid: 25253116
references.citation: Cancer. 2014 Oct 1;120(19):2946-54
references.pmid: 24798107
references.citation: J Clin Oncol. 2013 Oct 10;31(29):3631-8
references.pmid: 24002506
references.citation: Lancet Oncol. 2011 Feb;12(2):160-74
references.pmid: 21251875
references.citation: Contemp Clin Trials. 2013 May;35(1):15-24
references.pmid: 23395772
references.citation: Cancer. 2005 Apr 1;103(7):1494-502
references.pmid: 15726544
references.citation: Psychooncology. 2011 Jul;20(7):677-80
references.pmid: 21710503
references.citation: Int J Psychiatry Med. 1976-1977;7(1):1-15
references.pmid: 1052080
references.citation: J Clin Oncol. 2012 Apr 10;30(11):1160-77
references.pmid: 22412146
references.citation: Clin J Oncol Nurs. 2008 Oct;12(5):789-97
references.pmid: 18842535
references.citation: Curr Psychiatry Rep. 2012 Feb;14(1):23-9
references.pmid: 22068509
references.citation: Psychooncology. 2012 Dec;21(12):1275-84
references.pmid: 21919118
references.citation: J Natl Compr Canc Netw. 2007 Jan;5(1):99-103
references.pmid: 17239329
references.citation: Cancer Nurs. 1978 Oct;1(5):373-8
references.pmid: 250445
references.citation: J Natl Compr Canc Netw. 2013 Feb 1;11(2):214-21
references.pmid: 23411387
references.citation: Lancet. 2008 Jul 5;372(9632):8-10
references.pmid: 18603142
references.citation: J Clin Oncol. 2014 May 20;32(15):1605-19
references.pmid: 24733793
references.citation: J Natl Compr Canc Netw. 2013 Feb 1;11(2):223-6
references.pmid: 23411388
references.citation: J Natl Compr Canc Netw. 2013 Feb 1;11(2):190-209
references.pmid: 23411386